Cambridge Investment Research Advisors, Inc. Precigen, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Precigen, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 191,719 shares of PGEN stock, worth $287,578. This represents 0.0% of its overall portfolio holdings.
Number of Shares
191,719
Previous 220,719
13.14%
Holding current value
$287,578
Previous $247,000
15.79%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding PGEN
# of Institutions
140Shares Held
159MCall Options Held
136KPut Options Held
4.8K-
Third Security, LLC83.5MShares$125 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.9MShares$26.8 Million1.03% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.9MShares$16.3 Million0.02% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$15.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$12.5 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $312M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...